ELTX

Elicio Therapeutics (ELTX)

About Elicio Therapeutics (ELTX)

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Details

Daily high

$8.34

Daily low

$7.50

Price at open

$7.75

52 Week High

$12.62

52 Week Low

$4.60

Market cap

145.5M

Dividend yield

0.00%

Volume

115,821

Avg. volume

117,254

P/E ratio

-2.45

Elicio Therapeutics News